Ovarian hyperstimulation, hyperprolactinaemia and LH gonadotroph adenoma

Author： Castelo-Branco Camil   del Pino Marta   Valladares Esther  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.19, Iss.2, 2009-08, pp. : 153-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of ovarian hyperstimulation syndrome

By Genazzani Andrea Riccardo   Monteleone Patrizia   Papini Francesca   Artini Paolo Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2527-2534

Informa Healthcare

Access to resources Recommend Favorite

Genetics of ovarian hyperstimulation syndrome

By Rizk Botros  

Reproductive BioMedicine Online, Vol. 19, Iss. 1, 2009-07 ,pp. : 14-27

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Pharmacogenetics of controlled ovarian hyperstimulation

By de Castro Francisco   Morón Francisco J   Montoro Luis   Real Luis M   Ruiz Agustín  

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 629-637

Future Medicine

Access to resources Recommend Favorite

Recombinant LH in ovarian stimulation

By Caglar Gamze Sinem   Asimakopoulos Byron   Nikolettos Nikos   Diedrich Klaus   Al-Hasani Safaa  

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 774-785

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Exploiting LH in ovarian stimulation

By Alviggi C   Mollo A   Clarizia R   De Placido G  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 221-233

Reproductive Healthcare Ltd

Access to resources Recommend Favorite